These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8630670)

  • 1. Oral estrogen replacement therapy in postmenopausal women selectively raises levels and production rates of lipoprotein A-I and lowers hepatic lipase activity without lowering the fractional catabolic rate.
    Brinton EA
    Arterioscler Thromb Vasc Biol; 1996 Mar; 16(3):431-40. PubMed ID: 8630670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M; Kahri J; Pyörälä T; Puolakka J; Luotola H; Lappi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1997 Mar; 129(2):249-59. PubMed ID: 9105568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of Apo(a) and ApoB100 of lipoprotein(a) in women: effect of postmenopausal estrogen replacement.
    Su W; Campos H; Judge H; Walsh BW; Sacks FM
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3267-76. PubMed ID: 9745440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased intra-abdominal fat may lower HDL levels by increasing the fractional catabolic rate of Lp A-I in postmenopausal women.
    Vajo Z; Terry JG; Brinton EA
    Atherosclerosis; 2002 Feb; 160(2):495-501. PubMed ID: 11849676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia.
    Saku K; Gartside PS; Hynd BA; Mendoza SG; Kashyap ML
    Metabolism; 1985 Aug; 34(8):754-64. PubMed ID: 3927110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1991 Feb; 87(2):536-44. PubMed ID: 1899429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.
    Taskinen MR; Puolakka J; Pyörälä T; Luotola H; Bjäörn M; Kääriänen J; Lahdenperä S; Ehnholm C
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1215-21. PubMed ID: 8857916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity.
    Oscarsson J; Ottosson M; Johansson JO; Wiklund O; Mårin P; Björntorp P; Bengtsson BA
    Metabolism; 1996 Mar; 45(3):370-7. PubMed ID: 8606646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism: a kinetic study in control subjects and patients with type II diabetes mellitus.
    Frénais R; Nazih H; Ouguerram K; Maugeais C; Zaïr Y; Bard JM; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 May; 86(5):1962-7. PubMed ID: 11344192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
    Kagami A; Ishikawa T; Tada N; Sakamoto T; Mochizuki K; Nagano M; Moriguchi EH; Manabe M
    Clin Biochem; 1993 Apr; 26(2):101-7. PubMed ID: 8485855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein metabolism in subjects with hepatic lipase deficiency.
    Tilly-Kiesi M; Schaefer EJ; Knudsen P; Welty FK; Dolnikowski GG; Taskinen MR; Lichtenstein AH
    Metabolism; 2004 Apr; 53(4):520-5. PubMed ID: 15045702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II).
    Cheung MC; Sibley SD; Palmer JP; Oram JF; Brunzell JD
    J Lipid Res; 2003 Aug; 44(8):1552-8. PubMed ID: 12777470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
    Brinton EA; Eisenberg S; Breslow JL
    Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
    Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
    Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.
    Srivastava N; Chowdhury PR; Averna M; Srivastava RA
    Mol Cell Biochem; 2001 Apr; 220(1-2):87-93. PubMed ID: 11451387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
    Hazzard WR; Haffner SM; Kushwaha RS; Applebaum-Bowden D; Foster DM
    Metabolism; 1984 Sep; 33(9):779-84. PubMed ID: 6433146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
    Cheung MC; Walden CE; Knopp RH
    Metabolism; 1999 May; 48(5):658-64. PubMed ID: 10337871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.